{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T13:18:34Z","timestamp":1788095914640,"version":"build-2803163510"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/rlu.0b013e3182478bf2","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T01:42:30Z","timestamp":1339551750000},"page":"663-668","source":"Crossref","is-referenced-by-count":14,"title":["Apparent Relative Hypermetabolism of Selective Brain Areas in Huntington Disease and Importance of Reference Region for Analysis"],"prefix":"10.1097","volume":"37","author":[{"given":"Su Jin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Kyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Sil","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Whan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung-Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Han","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210204","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntingtons disease.","volume":"27","author":"Gil","year":"2008","journal-title":"Eur J Neurosci"},{"key":"R2-5-20210204","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ana.410230603","article-title":". Positron emission tomographic scan investigations of Huntingtons disease: cerebral metabolic correlates of cognitive function.","volume":"23","author":"Berent","year":"1988","journal-title":"Ann Neurol"},{"key":"R3-5-20210204","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":". Cortical and subcortical glucose consumption measured by PET in patients with Huntingtons disease.","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"key":"R4-5-20210204","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.expneurol.2008.12.015","article-title":"Functional imaging in Huntingtons disease.","volume":"216","author":"Paulsen","year":"2009","journal-title":"Exp Neurol"},{"key":"R5-5-20210204","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11307-007-0085-4","article-title":"Functional imaging of cerebral blood flow and glucose metabolism in Parkinsons disease and Huntingtons disease.","volume":"9","author":"Ma","year":"2007","journal-title":"Mol Imaging Biol"},{"key":"R6-5-20210204","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","article-title":"Mitochondria and Huntingtons disease pathogenesis: insight from genetic and chemical models.","volume":"1147","author":"Browne","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"R7-5-20210204","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":". Mitochondrial defect in Huntingtons disease caudate nucleus.","volume":"39","author":"Gu","year":"1996","journal-title":"Ann Neurol"},{"key":"R8-5-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10072-008-0969-3","article-title":"Molecular medicine: predicting and preventing Huntingtons disease.","volume":"29","author":"Squitieri","year":"2008","journal-title":"Neurol Sci"},{"key":"R9-5-20210204","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2174\/1389450111007011218","article-title":"Mitochondrial-associated metabolic changes and neurodegeneration in Huntingtons diseasefrom clinical features to the bench.","volume":"11","author":"Rosenstock","year":"2010","journal-title":"Curr Drug Targets"},{"key":"R10-5-20210204","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.neuroimage.2009.09.017","article-title":". Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies.","volume":"49","author":"Dukart","year":"2010","journal-title":"Neuroimage"},{"key":"R11-5-20210204","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroimage.2006.03.025","article-title":". Using a white matter reference to remove the dependency of global signal on experimental conditions in SPECT analyses.","volume":"32","author":"Spence","year":"2006","journal-title":"Neuroimage"},{"key":"R12-5-20210204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bbadis.2009.07.012","article-title":". Mitochondria in Huntingtons disease.","volume":"1802","author":"Damiano","year":"2010","journal-title":"Biochimica et Biophysica Acta"},{"key":"R13-5-20210204","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","article-title":". 3-Nitropropionic acid: a mitochondria toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntingtons disease.","volume":"95","author":"Brouillet","year":"2005","journal-title":"J Neurochem"},{"key":"R14-5-20210204","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1111\/j.1742-4658.2008.06612.x","article-title":". Increased glucose metabolism and ATP level in brain tissue of Huntingtons disease transgenic mice.","volume":"275","author":"Olah","year":"2008","journal-title":"FEBS J"},{"key":"R15-5-20210204","first-page":"1591","article-title":". Metabolic network abnormalities in early Huntingtons disease: an 18FFDG PET study.","volume":"42","author":"Feigin","year":"2001","journal-title":"J Nucl Med"},{"key":"R16-5-20210204","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":". Thalamic metabolism and symptom onset in preclinical Huntingtons disease.","volume":"130","author":"Feigin","year":"2007","journal-title":"Brain"},{"key":"R17-5-20210204","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-227X(98)80004-X","article-title":"Neural systems for control of voluntary actiona hypothesis.","volume":"35","author":"Hikosako","year":"1998","journal-title":"Adv Biophys"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0b013e3182478bf2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:25:58Z","timestamp":1621884358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201207000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0b013e3182478bf2","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}